1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with resolvin e2 in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (resolvin e2) | Trials (resolvin e2) | Recent Studies (post-2010) (resolvin e2) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 17 | 1 | 12 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dona, M; Fredman, G; Irimia, D; Krishnamoorthy, S; Oh, SF; Serhan, CN | 1 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and resolvin e2
Article | Year |
---|---|
Resolvin E2 formation and impact in inflammation resolution.
Topics: Animals; Chemotaxis; Down-Regulation; Eicosapentaenoic Acid; Female; Humans; Immunity, Innate; Inflammation; Integrins; Male; Mice; Neutrophils; Phagocytosis; Platelet Activating Factor | 2012 |